PI5K: A Potential Drug Target and Biomarker (P45643)

Target Name: Phosphatidylinositol 4-phosphate 5-kinase

NCBI ID: P45643

Phosphatidylinositol 4-phosphate 5-kinase

Other Name(s): PI5K

PI5K: A Potential Drug Target and Biomarker

Phosphatidylinositol 4-phosphate 5-kinase (PI5K) is a protein that is involved in various cellular processes in the cell. It is a key enzyme in the PI3K/AKT signaling pathway, which is a well-known signaling pathway that is involved in various cellular processes such as cell growth, differentiation, and survival. PI5K has been identified as a potential drug target and has been studied extensively in the context of various diseases, including cancer, inflammation, and neurological disorders.

PI5K is a protein that is composed of four subunits, including a catalytic subunit, two regulatory subunits, and a putative dimerization subunit. The catalytic subunit is responsible for catalyzing the conversion of phosphatidylinositol 4-phosphate (PIP) to phosphatidylinositol 4-phosphate 5-kinase (PI5K). This conversion is a critical step in the PI3K/AKT signaling pathway, as it allows the production of IP3, which is a key signaling molecule in this pathway.

PI5K has been shown to be involved in various cellular processes, including cell signaling, cell growth, and cell survival. It has been shown to play a role in the regulation of cell proliferation, cell migration, and the formation of blood vessels. It has also been shown to be involved in the regulation of inflammation and neurodegeneration.

One of the most promising aspects of PI5K is its potential as a drug target. Several studies have shown that inhibition of PI5K has been shown to be effective in treating various diseases, including cancer, neurological disorders, and inflammatory diseases. For example, inhibition of PI5K has been shown to be effective in treating breast cancer, by inhibiting the growth of cancer cells and increasing the sensitivity of these cells to chemotherapy.

In addition to its potential as a drug target, PI5K is also a potential biomarker for various diseases. The PI5K signaling pathway is well-established and has been used as a biomarker for various diseases, including cancer, neurodegeneration, and cardiovascular disease. For example, levels of PI5K have been shown to be elevated in the brains of individuals with Alzheimer's disease, which is a neurodegenerative disorder.

In conclusion, PI5K is a protein that is involved in various cellular processes and has been shown to play a role in the regulation of cell signaling, cell growth, and cell survival. It is a potential drug target and has been identified as a potential biomarker for various diseases. Further research is needed to fully understand the role of PI5K in cellular processes and its potential as a drug and biomarker.

Protein Name: Phosphatidylinositol 4-phosphate 5-kinase (nonspecified Subtype)

The "Phosphatidylinositol 4-phosphate 5-kinase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Phosphatidylinositol 4-phosphate 5-kinase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets